Frédéric Kridelka

2.5k total citations
53 papers, 721 citations indexed

About

Frédéric Kridelka is a scholar working on Oncology, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, Frédéric Kridelka has authored 53 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Molecular Biology and 13 papers in Obstetrics and Gynecology. Recurrent topics in Frédéric Kridelka's work include Endometrial and Cervical Cancer Treatments (11 papers), Lymphatic System and Diseases (10 papers) and Angiogenesis and VEGF in Cancer (7 papers). Frédéric Kridelka is often cited by papers focused on Endometrial and Cervical Cancer Treatments (11 papers), Lymphatic System and Diseases (10 papers) and Angiogenesis and VEGF in Cancer (7 papers). Frédéric Kridelka collaborates with scholars based in Belgium, France and Netherlands. Frédéric Kridelka's co-authors include Frédéric Goffin, Agnès Noël, Philippe Delvenne, Silvia Blacher, Katty Delbecque, Guy Jérusalem, Jean Doyen, Christine Gennigens, Cédric Balsat and Sylvie Streel and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Frédéric Kridelka

50 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Kridelka Belgium 17 252 220 131 127 124 53 721
Daniela Stramazzotti Italy 16 268 1.1× 197 0.9× 111 0.8× 95 0.7× 124 1.0× 43 894
Marcella Falchetti Italy 16 274 1.1× 225 1.0× 78 0.6× 231 1.8× 107 0.9× 19 803
Paweł Blecharz Poland 15 358 1.4× 234 1.1× 145 1.1× 110 0.9× 309 2.5× 72 1.0k
Silvia Varricchio Italy 16 205 0.8× 215 1.0× 78 0.6× 45 0.4× 87 0.7× 60 682
Inny Busmanis Singapore 15 185 0.7× 130 0.6× 210 1.6× 81 0.6× 164 1.3× 46 836
Hermann Brustmann Austria 18 270 1.1× 317 1.4× 114 0.9× 96 0.8× 88 0.7× 43 764
Chika Nwachukwu United States 14 228 0.9× 383 1.7× 184 1.4× 190 1.5× 344 2.8× 53 966
Sıtkı Tuzlalı Türkiye 16 312 1.2× 135 0.6× 187 1.4× 115 0.9× 370 3.0× 50 836
Rochelle A. Simon United States 14 157 0.6× 253 1.1× 121 0.9× 75 0.6× 137 1.1× 33 692
Gyeong Sin Park South Korea 15 206 0.8× 284 1.3× 126 1.0× 31 0.2× 94 0.8× 40 727

Countries citing papers authored by Frédéric Kridelka

Since Specialization
Citations

This map shows the geographic impact of Frédéric Kridelka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Kridelka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Kridelka more than expected).

Fields of papers citing papers by Frédéric Kridelka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Kridelka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Kridelka. The network helps show where Frédéric Kridelka may publish in the future.

Co-authorship network of co-authors of Frédéric Kridelka

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Kridelka. A scholar is included among the top collaborators of Frédéric Kridelka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Kridelka. Frédéric Kridelka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Danthine, Denis, Katty Delbecque, Frédéric Goffin, et al.. (2024). Lymph node assessment in cervical cancer: current approaches. Frontiers in Oncology. 14. 1435532–1435532. 2 indexed citations
2.
Streel, Sylvie, Vincent Bours, Katty Delbecque, et al.. (2023). Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer. International Journal of Molecular Sciences. 24(5). 4866–4866. 16 indexed citations
4.
Pintiaux, Axelle, et al.. (2023). Meningioma under progestin treatment, what attitude to adopt?. Maturitas. 173(10). 95–95. 1 indexed citations
5.
Leijenaar, Ralph T. H., Seán Walsh, Akshayaa Vaidyanathan, et al.. (2023). External validation of a radiomic signature to predict p16 (HPV) status from standard CT images of anal cancer patients. Scientific Reports. 13(1). 7198–7198. 6 indexed citations
6.
Gennigens, Christine, et al.. (2022). Recurrent or primary metastatic cervical cancer: current and future treatments. ESMO Open. 7(5). 100579–100579. 62 indexed citations
7.
Delbecque, Katty, Anne‐Sophie Van Rompuy, Étienne Marbaix, et al.. (2022). Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry. International Journal of Gynecological Cancer. 32(6). 740–745. 5 indexed citations
8.
Ferreira, Marta S., François Lucia, Vincent Jaouen, et al.. (2021). Convolutional neural networks for PET functional volume fully automatic segmentation: development and validation in a multi-center setting. European Journal of Nuclear Medicine and Molecular Imaging. 48(11). 3444–3456. 18 indexed citations
9.
Ferreira, Marta S., Pierre Lovinfosse, Caroline Rousseau, et al.. (2021). [18F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation. European Journal of Nuclear Medicine and Molecular Imaging. 48(11). 3432–3443. 44 indexed citations
10.
Kridelka, Frédéric, et al.. (2021). The pre-metastatic niche in lymph nodes: formation and characteristics. Cellular and Molecular Life Sciences. 78(16). 5987–6002. 61 indexed citations
11.
Velde, Maureen Van de, et al.. (2020). Tumor exposed-lymphatic endothelial cells promote primary tumor growth via IL6. Cancer Letters. 497. 154–164. 15 indexed citations
12.
Morfoisse, Florent, Charlotte Erpicum, Silvia Blacher, et al.. (2018). uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis. Nature Communications. 9(1). 5178–5178. 22 indexed citations
13.
García‐Caballero, Melissa, Maureen Van de Velde, Silvia Blacher, et al.. (2017). Modeling pre-metastatic lymphvascular niche in the mouse ear sponge assay. Scientific Reports. 7(1). 41494–41494. 21 indexed citations
14.
Frères, Pierre, Stéphane Wenric, Corinne Fasquelle, et al.. (2015). Circulating microRNA-based screening tool for breast cancer. Oncotarget. 7(5). 5416–5428. 49 indexed citations
16.
Vergote, Ignace, Russell J. Schilder, Charles H. Pippitt, et al.. (2014). A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer. Gynecologic Oncology. 135(1). 25–33. 15 indexed citations
18.
Chantraine, Frédéric, et al.. (2009). A rare case of placental choriangioma associated with neonatal diffuse hemangomatosis.. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 38(3).
19.
20.
Ryan, Mary, Frédéric Kridelka, Song Ren, et al.. (1989). RU-486 Inhibits Rat Gonadal Steroidogenesis. Hormone and Metabolic Research. 21(7). 369–371. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026